Mylan(R)

Corporate Profile

AT A GLANCE
Executive Chairman Robert J. Coury
Vice Chairman Rodney L. Piatt
CEO Heather Bresch
Corporate headquarters Pittsburgh, Pa., U.S.
Founded 1961, White Sulphur Springs, W.Va., U.S.
Workforce More than 20,000
2012 Revenue (USD) 6.8 billion
Product portfolio Approximately 1,100 separate products
Commercial footprint Approximately 140 countries and territories
Manufacturing capacity More than 45 billion doses
Memberships Fortune 500, S&P 500
Stock exchange listing Nasdaq: MYL
Pronunciation Mylan [mī-luhn]

Primary Businesses and Operations

Mylan's Global Reach

North America »
The second largest generic pharmaceutical company in the U.S. by sales volume, Mylan continues to capitalize on its presence in that market, which is the world's largest. Mylan's North American businesses include Mylan Pharmaceuticals, which is based in Morgantown, W.Va., Mylan's business in Canada, Mylan Technologies and UDL Laboratories.

APAC »
Mylan's Asia Pacific (APAC) presence includes market leading positions in Australia, through its Alphapharm subsidiary, Japan, the world's second largest pharmaceutical market, through its Mylan Seiyaku subsidiary, and New Zealand through its business in that country.

In addition, Mylan's strong active pharmaceutical ingredients (API) business, run by Mylan Laboratories Limited, is included in the company's APAC division. Headquartered in Hyderabad, India, Mylan Laboratories Limited operates nine API and intermediate manufacturing facilities located in India and China.
EMEA »
Mylan operates in Europe, the Middle East and Africa (EMEA), with manufacturing, packaging, distribution and marketing capabilities throughout the region. The division consistently holds top-five positions in several markets, including a No. 1 position in France.

Mylan EMEA businesses include those that operate under the Mylan name in Austria, Belgium, the Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Portugal, Scandinavia, Slovakia, Slovenia, Spain, Sweden, Switzerland, South Africa and United Kingdom.

Mylan’s other EMEA businesses include Arcana Arzneimittel, Generics Pharma Hellas and Gerard Laboratories.

Other Areas »